Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version has been incremented from v3.5.2 to v3.5.3, indicating a backend or release update without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-24T04:12:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:08:45.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Site revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:49.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to study content.
    Difference
    0.1%
    Check dated 2026-03-11T16:49:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.4.2', and the prior general funding/operating status notice was removed. These are administrative changes that do not affect the study content, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T01:20:58.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, with guidance to visit cc.nih.gov and opm.gov; updated the revision tag to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T22:10:21.000Z thumbnail image

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.